Listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of eCOA, its benefits, and ways to improve the technology.

Empower your study participants with IQVIA eCOA’s tailored user experiences, flexible event triggers for clinicians, comprehensive training resources, and 24/7 support for seamless study management.

Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.

As much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process.

Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

As actigraphy continues to advance, explore how improvements in device comfort and usability will enhance patient compliance, further optimizing its pivotal role in clinical research across various therapeutic domains.

Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.